CONCORD HC GP (02453)'s controlling shareholder Beijing Taihecheng pledged 35.6 million H shares, accounting for 4.54% of the total share capital.

CONCORD HC GP (02453) announced that on August 26, 2025, the company's controlling shareholder (as defined in the Listing Rules) Beijing Taihe Cheng Medical Technology Co., Ltd. (Beijing Taihe Cheng) has agreed to pledge 35.6 million H shares of the company to Shanghai Pudong Development Bank as the beneficiary, representing approximately 99.99% of the total number of shares directly held by Beijing Taihe Cheng. As of the date of this announcement, the H shares of the company pledged by Beijing Taihe Cheng account for approximately 4.54% of the total number of issued shares of the company. The directors are fully aware that Shanghai Pudong Development Bank is an independent third party to the company and its related parties.